Literature DB >> 15055586

P53 is a tumor suppressor gene.

Arnold J Levine1, Cathy A Finlay, Philip W Hinds.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15055586     DOI: 10.1016/s0092-8674(04)00036-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  44 in total

1.  Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.

Authors:  Hongtao Cheng; Biao Ma; Ran Jiang; Wei Wang; Hui Guo; Na Shen; Dapeng Li; Qunzi Zhao; Rui Wang; Pengfei Yi; Yue Zhao; Zeming Liu; Tao Huang
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wei-Hua Ren; Wen-Zhang Wang; Bo Peng; Long Yu
Journal:  Med Oncol       Date:  2010-06-15       Impact factor: 3.064

3.  Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody.

Authors:  Ning Xia; Lin Liu; Michael G Harrington; Jianxiu Wang; Feimeng Zhou
Journal:  Anal Chem       Date:  2010-11-12       Impact factor: 6.986

4.  Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation.

Authors:  Yongxing Wang; Young-Ah Suh; Maren Y Fuller; James G Jackson; Shunbin Xiong; Tamara Terzian; Alfonso Quintás-Cardama; James A Bankson; Adel K El-Naggar; Guillermina Lozano
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

5.  Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice.

Authors:  Reena Rani; Jie Li; Qishen Pang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 6.  The clinicopathological and prognostic significance of TP53 alteration in K27M mutated gliomas: an individual-participant data meta-analysis.

Authors:  Chengya Dong; Zhengrong Yuan; Qi Li; Yajie Wang
Journal:  Neurol Sci       Date:  2018-04-12       Impact factor: 3.307

Review 7.  Targeting mTOR network in colorectal cancer therapy.

Authors:  Xiao-Wen Wang; Yan-Jie Zhang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 8.  Tumor suppressor p53 meets microRNAs.

Authors:  Zhaohui Feng; Cen Zhang; Rui Wu; Wenwei Hu
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

9.  TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wen-Zhang Wang; Bo Peng; Wei-Hua Ren; Xian-Mei Yang; Long Yu
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

10.  AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53.

Authors:  Jung Min Han; Bum-Joon Park; Sang Gyu Park; Young Sun Oh; So Jung Choi; Sang Won Lee; Soon-Kyung Hwang; Seung-Hee Chang; Myung-Haing Cho; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.